Galleri® in the Medicare Population.
NCT: NCT05673018 · RECRUITING
광고
NCT IDNCT05673018
상태RECRUITING
시작일2024-07-12
SponsorGRAIL, Inc. (INDUSTRY)
First posted
Last updated
간략 요약
This multi-center comparative prospective cohort study is designed to assess the real world clinical impact, including safety and test performance, of Galleri®, a blood-based multi-cancer early detection (MCED) test. The study will seek enrollment that is representative of the Medicare population.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.